Aminzadeh Zohreh, Asl Rahim Taghizadeh
Associate Professor of Infectious Diseases, Shaheed Beheshti Medical University, Loghman Hakim Hospital, Infectious Diseases & Research Center, Iran.
Int J Prev Med. 2011 Apr;2(2):79-81.
Current international guidelines recommend 6-9 months of Isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in children exposed to smear positive tuberculosis (TB) patients. The aim of the present study was to evaluate the adherence to a six-month of supervised INH prophylaxis program and outcome in children with household exposure to an adult pulmonary tuberculosis index case in Varamin city, Tehran, Iran.
This cross sectional study was conducted among household contacts in Varamin city, between 1997- 1998. All children <6 years old with a household contact with an adult pulmonary tuberculosis index case were screened for tuberculosis and given supervised INH preventive chemotherapy once active tuberculosis was excluded as planned. Adherence and outcome were monitored.
In total, 31 index cases and 128 household contact cases were identified; 23 (18%) children <6 years old experienced household exposure, who were fully evaluated. two children were treated for active tuberculosis and 15 (12%) children received preventive chemotherapy. All children completed 6 months of supervised INH prophylaxis with normal clinical examination in 3 and 6 months after beginning INH prophylaxis. No side effects (peripheral neuropathy or liver damage) were reported or observed within this study.
Strategy of six months of supervised INH chemoprophylaxis is successful, particularly in children who are at a high risk to progress to disease following exposure.
当前国际指南推荐使用6 - 9个月的异烟肼(INH)预防性化疗,以预防接触涂片阳性肺结核(TB)患者的儿童发生活动性肺结核。本研究的目的是评估伊朗德黑兰瓦拉明市家庭接触成年肺结核指数病例的儿童对为期6个月的监督性INH预防方案的依从性及结果。
本横断面研究于1997 - 1998年在瓦拉明市的家庭接触者中进行。所有与成年肺结核指数病例有家庭接触的6岁以下儿童均接受肺结核筛查,一旦按计划排除活动性肺结核,即给予监督性INH预防性化疗。对依从性和结果进行监测。
共识别出31例指数病例和128例家庭接触病例;23名(18%)6岁以下儿童有家庭接触史,并接受了全面评估。2名儿童接受了活动性肺结核治疗,15名(12%)儿童接受了预防性化疗。所有儿童均完成了6个月的监督性INH预防治疗,在开始INH预防治疗后的3个月和6个月临床检查均正常。本研究中未报告或观察到任何副作用(周围神经病变或肝损伤)。
为期6个月的监督性INH化学预防策略是成功的,尤其是对于接触后进展为疾病风险较高的儿童。